Back

SARM1 detection in oligodendrocytes but not Schwann cells though sarm1/Sarm1 deletion does not perturb CNS nor PNS myelination in zebrafish and mice.

Fazal, S. V.; Mutschler, C.; Chen, C.; Turmaine, M.; Chen, C.-Y.; Hsueh, Y.-P.; Loreto, A.; Casillas-Bajo, A.; Cabedo, H.; Franklin, R. J.; Barker, R. A.; Monk, K.; Steventon, B.; Coleman, M.; Gomez-Sanchez, J. A.; Arthur-Farraj, P.

2022-12-09 neuroscience
10.1101/2022.12.08.519209 bioRxiv
Show abstract

SARM1 is a central regulator of programmed axon death and is required to initiate axon self-destruction after traumatic and toxic insults to the nervous system. Abnormal activation of this axon degeneration pathway is increasingly recognized as a contributor to human neurological disease and SARM1 knockdown or inhibition has become an attractive therapeutic strategy to preserve axon loss in a variety of disorders of the peripheral and central nervous system. Despite this, it remains unknown whether Sarm1/SARM1 is present in myelinating glia and whether it plays a role in myelination in the PNS or CNS. It is important to answer these questions to understand whether future therapies inhibiting SARM1 function may have unintended deleterious impacts on myelination. Here we show that Sarm1 mRNA is present in oligodendrocytes in zebrafish but only detectable at low levels in Schwann cells in both zebrafish and mice. We find SARM1 protein is readily detectable in murine oligodendrocytes in vitro and in vivo and activation of endogenous SARM1 in oligodendrocytes induces cell death. In contrast, SARM1 protein is not detectable in Schwann cells and satellite glia in the adult murine nervous system. Cultured Schwann cells contain negligible functional SARM1 and are insensitive to specific SARM1 activators. Using zebrafish and mouse Sarm1 mutants, we show that SARM1 is not required for initiation of myelination nor myelin sheath maintenance by oligodendrocytes and Schwann cells. Thus, strategies to inhibit SARM1 function in the nervous system to treat neurological disease are unlikely to perturb myelination in humans. Main PointsO_LISARM1 protein is detectable in oligodendrocytes but not in Schwann cells C_LIO_LIOligodendrocytes but not Schwann cells die in response to endogenous SARM1 activation C_LIO_LICNS nor PNS myelination, in zebrafish and mice, is hindered by loss of sarm1/Sarm1 C_LI

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Neurobiology of Disease
134 papers in training set
Top 0.4%
10.2%
2
eneuro
389 papers in training set
Top 0.4%
10.2%
3
Frontiers in Cellular Neuroscience
79 papers in training set
Top 0.1%
9.2%
4
Brain
154 papers in training set
Top 0.9%
6.4%
5
eLife
5422 papers in training set
Top 17%
4.9%
6
The Journal of Neuroscience
928 papers in training set
Top 3%
4.3%
7
Journal of Neurochemistry
50 papers in training set
Top 0.1%
3.7%
8
Brain Communications
147 papers in training set
Top 0.6%
3.7%
50% of probability mass above
9
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 24%
2.8%
10
ASN Neuro
10 papers in training set
Top 0.1%
2.5%
11
Nature Communications
4913 papers in training set
Top 45%
2.5%
12
Cell Reports
1338 papers in training set
Top 20%
2.4%
13
Scientific Reports
3102 papers in training set
Top 49%
2.1%
14
PLOS Genetics
756 papers in training set
Top 7%
2.1%
15
Frontiers in Molecular Neuroscience
43 papers in training set
Top 0.2%
1.9%
16
Glia
74 papers in training set
Top 0.2%
1.8%
17
Frontiers in Neuroscience
223 papers in training set
Top 4%
1.7%
18
PLOS Biology
408 papers in training set
Top 9%
1.7%
19
PLOS ONE
4510 papers in training set
Top 53%
1.7%
20
Neuron
282 papers in training set
Top 6%
1.5%
21
Frontiers in Neurology
91 papers in training set
Top 4%
1.2%
22
Journal of Biological Chemistry
641 papers in training set
Top 3%
1.1%
23
iScience
1063 papers in training set
Top 26%
0.9%
24
Nature Neuroscience
216 papers in training set
Top 6%
0.8%
25
Experimental Neurology
57 papers in training set
Top 1%
0.8%
26
Neuroscience
88 papers in training set
Top 3%
0.8%
27
Disease Models & Mechanisms
119 papers in training set
Top 3%
0.8%
28
EMBO Molecular Medicine
85 papers in training set
Top 4%
0.8%
29
Molecular and Cellular Neuroscience
18 papers in training set
Top 0.6%
0.8%
30
Current Biology
596 papers in training set
Top 14%
0.8%